SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2104)10/4/1997 9:53:00 PM
From: BarryH   of 6136
 
So you think I'm giving AGPH's organization , management and pipeline too much credit in the market evaluation of the company?

AS for my market cap numbers...S&P puts AGPH at $1,433,930,000 as of close of business Friday on 30,030,000 shares and VRTX at $875,220,000 on 25,096,000 shares.

The total shares numbers are different on Billkirn's webpage..20,84,000 and 17,189,000 respectively.

Any idea which set of numbers are right, if any?

Just for the record..I presently have a long position and am loaded up on Nov 50 Call's (which are break even after yesterday's trading, thank God.) I have never shorted or bought puts on this stock...

I've set a target of 70 for myself before I re-evaluate..and hopefully that will be by the end of the year..

What do you think the mid term peak ( 6 months) for this stock will be?

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext